| Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients PP Lee, C Yee, PA Savage, L Fong, D Brockstedt, JS Weber, D Johnson, ... Nature medicine 5 (6), 677-685, 1999 | 1380 | 1999 |
| Tumor-specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis A Schietinger, M Philip, VE Krisnawan, EY Chiu, JJ Delrow, RS Basom, ... Immunity 45 (2), 389-401, 2016 | 687 | 2016 |
| Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer DT Le, A Wang-Gillam, V Picozzi, TF Greten, T Crocenzi, G Springett, ... Journal of clinical Oncology 33 (12), 1325-1333, 2015 | 670 | 2015 |
| Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes V Auerbuch, DG Brockstedt, N Meyer-Morse, M O'Riordan, DA Portnoy The Journal of experimental medicine 200 (4), 527-533, 2004 | 561 | 2004 |
| Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity CW Chan, E Crafton, HN Fan, J Flook, K Yoshimura, M Skarica, ... Nature medicine 12 (2), 207-213, 2006 | 545 | 2006 |
| Dendritic cells injected via different routes induce immunity in cancer patients L Fong, D Brockstedt, C Benike, L Wu, EG Engleman The Journal of Immunology 166 (6), 4254-4259, 2001 | 500 | 2001 |
| A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune … DT Le, DG Brockstedt, R Nir-Paz, J Hampl, S Mathur, J Nemunaitis, ... Clinical cancer research 18 (3), 858-868, 2012 | 395 | 2012 |
| Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy L Fong, D Brockstedt, C Benike, JK Breen, G Strang, CL Ruegg, ... The Journal of Immunology 167 (12), 7150-7156, 2001 | 372 | 2001 |
| Listeria-based cancer vaccines that segregate immunogenicity from toxicity DG Brockstedt, MA Giedlin, ML Leong, KS Bahjat, Y Gao, W Luckett, ... Proceedings of the National Academy of Sciences 101 (38), 13832-13837, 2004 | 367 | 2004 |
| Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide. DT Kim, DJ Mitchell, DG Brockstedt, L Fong, GP Nolan, CG Fathman, ... Journal of immunology (Baltimore, Md.: 1950) 159 (4), 1666-1668, 1997 | 256 | 1997 |
| Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells MV Goldberg, CH Maris, EL Hipkiss, AS Flies, L Zhen, RM Tuder, ... Blood, The Journal of the American Society of Hematology 110 (1), 186-192, 2007 | 252 | 2007 |
| Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation L Cohn, B Chatterjee, F Esselborn, A Smed-Sörensen, N Nakamura, ... Journal of Experimental Medicine 210 (5), 1049-1063, 2013 | 231 | 2013 |
| Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration DG Brockstedt, GM Podsakoff, L Fong, G Kurtzman, W Mueller-Ruchholtz, ... Clinical Immunology 92 (1), 67-75, 1999 | 205 | 1999 |
| Results from a phase IIb, randomized, multicenter study of GVAX pancreas and CRS-207 compared with chemotherapy in adults with previously treated metastatic pancreatic … DT Le, VJ Picozzi, AH Ko, ZA Wainberg, H Kindler, A Wang-Gillam, ... Clinical Cancer Research 25 (18), 5493-5502, 2019 | 202 | 2019 |
| Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer. L Fong, CL Ruegg, D Brockstedt, EG Engleman, R Laus Journal of immunology (Baltimore, Md.: 1950) 159 (7), 3113-3117, 1997 | 188 | 1997 |
| Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity DG Brockstedt, KS Bahjat, MA Giedlin, W Liu, M Leong, W Luckett, Y Gao, ... Nature medicine 11 (8), 853-860, 2005 | 178 | 2005 |
| A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice BP Keenan, Y Saenger, MI Kafrouni, A Leubner, P Lauer, A Maitra, ... Gastroenterology 146 (7), 1784-1794. e6, 2014 | 169 | 2014 |
| Listeria monocytogenes as a vaccine vector: virulence attenuation or existing antivector immunity does not diminish therapeutic efficacy H Starks, KW Bruhn, H Shen, RA Barry, TW Dubensky, D Brockstedt, ... The Journal of Immunology 173 (1), 420-427, 2004 | 122 | 2004 |
| Evaluation of cyclophosphamide/GVAX pancreas followed by listeria-mesothelin (CRS-207) with or without nivolumab in patients with pancreatic cancer T Tsujikawa, T Crocenzi, JN Durham, EA Sugar, AA Wu, B Onners, ... Clinical Cancer Research 26 (14), 3578-3588, 2020 | 107 | 2020 |
| Tumors establish resistance to immunotherapy by regulating Treg recruitment via CCR4 LA Marshall, S Marubayashi, A Jorapur, S Jacobson, M Zibinsky, ... Journal for immunotherapy of cancer 8 (2), 2020 | 101 | 2020 |
